What does LTRA stand for?

Leukotriene Receptor Antagonist

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Long-Term Recall (neuropsychology) Long-Term Return Rate (TL 9000) Loop Transfer Recovery Loss of Therapeutic Response (drug efficacy) Lossless Trace Reduction Love Trust Respect Loving Tender Relationship Low Thermal Resistance Lower Troposphere Radar Lower Trunk Rotation (physical therapy)		Long Term Remedial Action Long-Term Rental Assistance Program (City of Miami Community Development; Miami, FL) Long-Term Repopulating Ability (stem cells) Long-Term Response Action Low Temperature Requirement A (protein) Laboratory for Turbulence Research in Aerospace and Combustion (Australia) Language Translation Resource Automation Console Large TRACON (FAA) Long Term Research on Agricultural Systems (University of California Davis) Left, Top, Right, Bottom

Samples in periodicals archive:

Zafirlukast Zafirlukast is a leukotriene receptor antagonist.

Clinical application of nonsteroidal agents

Other leukotriene modifying medications include Accolate (zafirlukast), which is also a leukotriene receptor antagonist, and Zyflo and Zyflo CR (zileuton), a leukotriene synthesis inhibitor.

FDA reviewing safety of Merck, Mylan drugs

Alternative -- Low-dose or (if needed) medium-dose inhaled corticosteroid and either leukotriene receptor antagonist or theophylline (serum level 5-12 mcg/mL).

Asthma guidelines cover treatment in pregnancy: Gynecologists' group ...

5 LEUKOTRIENE RECEPTOR ANTAGONISTS Data regarding the safety of leukotriene antagonists in pregnancy are extremely limited.

Synod of Atlantic Provinces meets in youthful setting. (News)

Merck's montelukast (Singulair) is the second FDA-approved leukotriene receptor antagonist and the third antileukotriene drug for this indication.

Montelukast Sodium Tablets for Asthma

Zafirlukast, a member of a class of drugs known as leukotriene receptor antagonists, recently was approved by the Food and Drug Administration.

NEW ASTHMA DRUGS CAN HELP PREVENT SYMPTOMS

Rubin said, the drug has a far broader pharmacologic profile than leukotriene receptor antagonists which target a single receptor.

Critical Therapeutics President and CEO Presents at Scientific ...

These patients seem to respond favorably to inhaled corticosteroids and leukotriene receptor antagonists.

A closer look at asthma, part II